ImmunityBio (IBRX)
(Delayed Data from NSDQ)
$3.44 USD
-0.08 (-2.27%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $3.44 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.18 | 0.00% |
Earnings Summary
For their last quarter, ImmunityBio (IBRX) reported earnings of -$0.20 per share, missing the Zacks Consensus Estimate of -$0.17 per share. This reflects a negative earnings surprise of 17.65%. Look out for IBRX's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.18 per share, reflecting a year-over-year increase of 5.26%.
Earnings History
Price & Consensus
Zacks News for IBRX
ImmunityBio (IBRX) Reports Q2 Loss, Lags Revenue Estimates
IBRX: What are Zacks experts saying now?
Zacks Private Portfolio Services